Breakpoint Therapeutics aims to advance the clinical improvement of very first-in-class oncology drugs that interfere with DNA restore and replication stress tolerance pathways. The company’s therapeutics target the DNA damage response in cancer cells with repair and replication stress tolerance pathways, enabling the medical organisation and hospitals to create medication https://is.gd/VVmTMJ